Cita APA

C, C., MA, M., AC, C., M, C., T, D., A, M., & Á, R. (2025). Effectiveness and safety of liposomal rapamycin for the treatment of facial angiofibromas in tuberous sclerosis.

Citación estilo Chicago

C, Cortell-Fuster, Martínez-Gómez MA, Cercós-Lleti AC, Climente-Martí M, Díaz-Corpas T, Mateu-Puchades A, y Revert-Fernández Á. Effectiveness and Safety of Liposomal Rapamycin for the Treatment of Facial Angiofibromas in Tuberous Sclerosis. 2025.

Cita MLA

C, Cortell-Fuster, et al. Effectiveness and Safety of Liposomal Rapamycin for the Treatment of Facial Angiofibromas in Tuberous Sclerosis. 2025.